about
Endothelial cell phenotypes in the rheumatoid synovium: activated, angiogenic, apoptotic and leakyInhibitors of mitogen-activated protein kinases downregulate COX-2 expression in human chondrocytesMicrosomal prostaglandin E synthase-1: the inducible synthase for prostaglandin E2Correlations between both the expression levels of inflammatory mediators and growth factor in medial perimeniscal synovial tissue and the severity of medial knee osteoarthritis.A targeted lipidomics approach to the study of eicosanoid release in synovial joints.Long term NSAID treatment inhibits COX-2 synthesis in the knee synovial membrane of patients with osteoarthritis: differential proinflammatory cytokine profile between celecoxib and aceclofenacReactive oxygen species induce Cox-2 expression via TAK1 activation in synovial fibroblast cells.Prostaglandin E2 differentially modulates proinflammatory/prodestructive effects of TNF-alpha on synovial fibroblasts via specific E prostanoid receptors/cAMP.New insights into eicosanoid biosynthetic pathways: implications for arthritis.Potential roles of microsomal prostaglandin E synthase-1 in rheumatoid arthritis.Transforming growth factor β activated kinase 1: a potential therapeutic target for rheumatic diseases.Prostaglandin E2 activates Rap1 via EP2/EP4 receptors and cAMP-signaling in rheumatoid synovial fibroblasts: involvement of Epac1 and PKA.TAK1 mediates the collagen-II-dependent induction of the COX-2 gene and PGE2 release in primary human chondrocytes.Cyclooxygenase-2 is upregulated in inflamed gingival tissues.Cortisol-mediated adhesion of synovial fibroblasts is dependent on the degradation of anandamide and activation of the endocannabinoid system
P2860
Q24793680-F7B3F180-6C89-4078-8E2B-A584193963B7Q24815106-21195D85-E4BB-4E9E-BE39-B047E5DC34B5Q24816942-7D4A7A3E-A0D0-482B-8491-ADB7AD6B828DQ35013171-AA455FA3-CD53-4F27-9FAA-3270A9FAB755Q35617666-D16A3E56-B753-4217-A61F-D5F9FC95B79EQ35637500-F828B68C-02C6-41F3-9836-C48BB15CC818Q35767998-5B79B279-5E9C-4CA1-9367-0C4336152D94Q37357857-79CC8399-F8DC-4CAE-9139-03D97B1CEB0AQ37754734-9CDC4A9C-C2DE-4ACB-92B7-AFD6ED774B2AQ37981647-974F97FE-831B-4BC0-A50E-DA2B31BBC754Q38934371-6CA4A09C-6B22-435D-AD16-FB1362B38A19Q39847792-F233A840-5D94-47EF-8A7A-2A0BD1705A4CQ42983648-CA3BA0AB-DA82-458F-8805-B7B3DBEFDC62Q43598355-3402D1A5-29CE-430F-80A8-B0BC8F98B5B1Q58042755-0CA2F655-26BE-4947-99D7-888B4CE5388E
P2860
description
1999 nî lūn-bûn
@nan
1999 թուականի Յուլիսին հրատարակուած գիտական յօդուած
@hyw
1999 թվականի հուլիսին հրատարակված գիտական հոդված
@hy
1999年の論文
@ja
1999年論文
@yue
1999年論文
@zh-hant
1999年論文
@zh-hk
1999年論文
@zh-mo
1999年論文
@zh-tw
1999年论文
@wuu
name
COX-2 in synovial tissues.
@ast
COX-2 in synovial tissues.
@en
type
label
COX-2 in synovial tissues.
@ast
COX-2 in synovial tissues.
@en
prefLabel
COX-2 in synovial tissues.
@ast
COX-2 in synovial tissues.
@en
P356
P1476
COX-2 in synovial tissues.
@en
P2093
L J Crofford
P304
P356
10.1053/JOCA.1999.0226
P577
1999-07-01T00:00:00Z